zovegalisib — Topline data
2026
Breast cancer triplet data and frontline Phase 3 plans expected to be announced in 2026Source filing
RLAY biotech catalysts & pipeline
RELAY THERAPEUTICS INC · Data as of 2026-09-08
Upcoming catalysts
zovegalisib — Interim data
Late 2026
Data and regulatory update by year-end 2026Source filing
zovegalisib — Regulatory decision
Late 2026
Regulatory update to confirm design for planned Phase 3 trial in 1L endocrine sensitive breast cancer by year-end 2026Source filing
zovegalisib — Interim data
1H 2027
Data update for Phase 1/2 triplet combination in 1H 2027Source filing